HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF Class U Units

ETF | Others |

Last Closing

CAD 7.57

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.52K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA Horizons High Interest Savings..

+0.01 (+0.02%)

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

+0.03 (+0.17%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.24 (-0.38%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

-0.26 (-0.64%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.05 (+0.23%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

-0.15 (-0.51%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

+0.03 (+0.32%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

N/A

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.07 (-0.33%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.20% 6% D- 27% F
Dividend Return 4.47% 99% N/A 88% B+
Total Return 1.28% 10% F 30% F
Trailing 12 Months  
Capital Gain -11.36% 7% C- 29% F
Dividend Return 6.14% 100% F 92% A
Total Return -5.21% 9% A- 32% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain -2.73% 9% A- 23% F
Dividend Return 2.25% 41% F 41% F
Total Return 5.00% 95% A 86% B+
Risk Return Profile  
Volatility (Standard Deviation) 4.12% 68% D+ 85% B
Risk Adjusted Return 54.62% 47% F 63% D
Market Capitalization N/A N/A N/A N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.